Stay updated on TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.

Latest updates to the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, indicating a minor site revision. No core content, study identifiers, or trial details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check24 days agoChange DetectedAdded extensive Locations sections with study sites across multiple regions (US states, Canadian provinces, Europe, Asia and Australia). Updated the page revision to v3.3.3.SummaryDifference2%

- Check46 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2, which appears to be a minor system update with no changes to core page content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange DetectedThe Publications section now notes that publications are provided voluntarily and are automatically filled from PubMed, and the page revision is updated to v3.3.1.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded the study site entry: Tainan, Taiwan 704. Removed the previous listing 'Tainan City, Taiwan 704' and removed the government funding status notice.SummaryDifference0.1%

- Check74 days agoChange DetectedThe study status changed from Active, not recruiting to Completed (as of 2025-10-29).SummaryDifference0.3%

Stay in the know with updates to TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.